Halyna Pylypenko

3.9k citations
40 papers · 3k · 4 hit papers · h-index 17

Impact in

  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematology top 1%
    • Multiple Myeloma Research and Treatments

Papers in

    • Chronic Lymphocytic Leukemia Research 9
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 8
    • Multiple Myeloma Research and Treatments 14

Halyna Pylypenko

39 papers receiving 2.9k citations

Halyna Pylypenko's Hit Papers

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study 2020 · 278 citations
2780+5+10Years since publication250500750

Peers

Halyna Pylypenko
Comparison fields: 5 of 70
  • Genetics 925
  • Hematology 977
  • Pathology and Forensic Medicine 415
  • Oncology 263
  • Molecular Biology 268
Replace Marie‐Christine Kyrtsonis with:
Marie‐Christine Kyrtsonis Greece
Diane L. Warren United States
Sonja Burgstaller Austria
Christopher Pocock United Kingdom
Olga S. Samoilova United States
Miklós Egyed Hungary
Gunnar Juliusson Sweden
Abdulraheem Yacoub United States
Eirini Katodritou Greece
Ira V Gupta United States
Halyna Pylypenko relative to Marie‐Christine Kyrtsonis Greece Marie‐Christine Kyrtsonis's profile →
Citations per field
00.5×1.6×
Marie‐Christine Kyrtsonis · 1×
Citations per year

Countries citing papers authored by Halyna Pylypenko

Since Specialization
Citations

This map shows the geographic impact of Halyna Pylypenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halyna Pylypenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halyna Pylypenko more than expected).

Fields of papers citing papers by Halyna Pylypenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halyna Pylypenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halyna Pylypenko. The network helps show where Halyna Pylypenko may publish in the future.

Co-authors

The 25 scholars most cited alongside Halyna Pylypenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Halyna Pylypenko Line = papers co-authored together Halyna Pylypenko links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Hit paper breakdown →
2011793
2 2015363
3
Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
Hit paper breakdown →
2015313
4
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
Hit paper breakdown →
2020278
5
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2020253
6 2015168
7 2012114
8 2023106
9 2018103
10 2018101
11 202286
12 202358
13 201532
14 201627
15 202127
16 202023
17 202120
18 202115
19 201712
20 202112

About Halyna Pylypenko

Halyna Pylypenko is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Nuclear Energy and Engineering, having authored 40 papers that have together received 3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Genetics (925 citations), Hematology (977 citations), Pathology and Forensic Medicine (415 citations), Oncology (263 citations) and Molecular Biology (268 citations). Halyna Pylypenko has collaborated with scholars based in United States, Poland and Czechia. Frequent co-authors include Helgi J. Van de Velde, Sebastian Grosicki, Tadeusz Robak, Philippe Moreau, William M Deraedt, Bertrand Arnulf, Xavier P Leleu, Zvenyslava Masliak, Huaibao Feng and Grigoriy B. Rekhtman. Their work appears in journals such as Blood, Haematologica, The Lancet Oncology, HemaSphere and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact